{"id":"tasosartan","rwe":[],"tags":[{"label":"tasosartan","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Type-1 angiotensin II receptor","category":"target"},{"label":"AGTR1","category":"gene"},{"label":"C09CA05","category":"atc"},{"label":"Active","category":"status"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Angiotensin II Type 1 Receptor Blockers","category":"pharmacology"},{"label":"Angiotensin Receptor Antagonists","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"verdia","offLabel":[],"synonyms":["tasosartan","verdia","ANA756","ANA-756"],"timeline":[],"approvals":[],"brandName":"Verdia","ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Type-1 angiotensin II receptor","targets":[{"gene":"AGTR1","source":"DrugCentral","target":"Type-1 angiotensin II receptor","protein":"Type-1 angiotensin II receptor"}],"modality":"Small Molecule","drugClass":"tasosartan","explanation":"Think of it like a traffic light: angiotensin II is like a red light that tells blood vessels to constrict and blood pressure to rise. Verdia blocks this red light, allowing blood vessels to relax and blood pressure to decrease. This helps to lower blood pressure and reduce the risk of heart disease.","oneSentence":"Verdia works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure.","technicalDetail":"Tasosartan selectively and competitively binds to the angiotensin II type 1 receptor (AT1R), preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II, thereby reducing blood pressure and promoting vasodilation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3839","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TASOSARTAN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:46:57.788607","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:49:15.850736+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"losartan","drugSlug":"losartan","fdaApproval":"1995-04-14","patentExpiry":"Oct 7, 2041","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"eprosartan","drugSlug":"eprosartan","fdaApproval":"1997-12-22","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"valsartan","drugSlug":"valsartan","fdaApproval":"1996-12-23","genericCount":22,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"irbesartan","drugSlug":"irbesartan","fdaApproval":"1997-09-30","genericCount":23,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"candesartan cilexetil","drugSlug":"candesartan-cilexetil","fdaApproval":"1998-06-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"telmisartan","drugSlug":"telmisartan","fdaApproval":"1998-11-10","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"olmesartan medoxomil","drugSlug":"olmesartan-medoxomil","fdaApproval":"2002-04-25","genericCount":25,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"azilsartan medoxomil","drugSlug":"azilsartan-medoxomil","fdaApproval":"2011-02-25","relationship":"same-class"}],"genericName":"tasosartan","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"losartan","brandName":"losartan","genericName":"losartan","approvalYear":"1995","relationship":"same-class"},{"drugId":"eprosartan","brandName":"eprosartan","genericName":"eprosartan","approvalYear":"1997","relationship":"same-class"},{"drugId":"valsartan","brandName":"valsartan","genericName":"valsartan","approvalYear":"1996","relationship":"same-class"},{"drugId":"irbesartan","brandName":"irbesartan","genericName":"irbesartan","approvalYear":"1997","relationship":"same-class"},{"drugId":"candesartan-cilexetil","brandName":"candesartan cilexetil","genericName":"candesartan cilexetil","approvalYear":"1998","relationship":"same-class"},{"drugId":"telmisartan","brandName":"telmisartan","genericName":"telmisartan","approvalYear":"1998","relationship":"same-class"},{"drugId":"olmesartan-medoxomil","brandName":"olmesartan medoxomil","genericName":"olmesartan medoxomil","approvalYear":"2002","relationship":"same-class"},{"drugId":"azilsartan-medoxomil","brandName":"azilsartan medoxomil","genericName":"azilsartan medoxomil","approvalYear":"2011","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"48G92V856H","CHEBI":"CHEBI:135666","INN_ID":"7334","UMLSCUI":"C0662811","ChEMBL_ID":"CHEMBL432162","KEGG_DRUG":"D06010","DRUGBANK_ID":"DB01349","PUBCHEM_CID":"60919","IUPHAR_LIGAND_ID":"6898","MESH_SUPPLEMENTAL_RECORD_UI":"C086167"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"50%"},"publicationCount":18,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C09CA05","allCodes":["C09CA05"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Verdia is a small molecule that acts as a Type-1 angiotensin II receptor antagonist. It is classified as an antagonist and has synonyms including ANA-756, TASOSARTAN, and WAY-ANA-756.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:49:15.850736+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}